Overall Technical outlook

Price Summary

Aurobindo Pharma Limited's stock, on 2026-04-30 opened at 1392.0, climbed to a high of 1404.0, dropped to a low of 1378.6, and closed up -0.18% at 1389.5, with 606333 shares traded.
During the 52-week span, the stock hit a high of 1435.4 and a low of 1022.2.

Technicals

Support and Resistance: The price of 1389.5 is supported at 1311.9 and faces resistance at 1435.4. This range suggests key levels for AUROPHARMA where the price may stabilize, with 1311.9 acting as a support and 1435.4 as a cap on gains.
AUROPHARMA supportResistance 58c746
Support/Resistance for AUROPHARMA


Aroon: The current state of the AROON is neutral for AUROPHARMA, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
AUROPHARMA aroon 58c746
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for AUROPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AUROPHARMA bbands 58c746
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR for Aurobindo Pharma Limited has recently turned from bullish to bearish, suggesting a potential trend change. This reversal could be a strong bearish signal if it aligns with other market indicators. Investors should monitor the situation and wait for further confirmation before making any moves.
AUROPHARMA psar 58c746
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
AUROPHARMA stoch 58c746
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the wavering slopes of the 20 and 50 SMAs indicate that this momentum is weakening. This could be an early sign that the market is preparing for a bullish reversal, as the current downward trend begins to lose steam. Investors may soon see a shift towards more positive price action as the trend starts to change.
AUROPHARMA trippleSMA 58c746
Tripple SMA chart for Aurobindo Pharma Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.